ArticleCancers2024

Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer.

Andrea Sesma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.